DNAnexus

With the convergence of generative AI and complex omics data creating the next wave of innovation, how will it impact the future of life sciences? Explore this and more with some of the brightest minds in the industry at Precision Perspectives: https://lnkd.in/gQDd3BFu Precision Perspectives is an exclusive event bringing together innovators, opinion leaders, and strategic partners for a night of forward-thinking discussion and high-level networking. You’ll hear visionary talks and participate in elite networking while enjoying appetizers and drinks in the heart of San Francisco. Limited seats remain, secure your spot today!

With the convergence of generative AI and complex omics data creating the next wave of innovation, how will it impact the future of life sciences? Explore this and more with some of the brightest minds in the industry at Precision Perspectives: https://lnkd.in/gQDd3BFu Precision Perspectives is an exclusive event bringing together innovators, opinion leaders, and strategic partners for a night of forward-thinking discussion and high-level networking. You’ll hear visionary talks and participate in elite networking while enjoying appetizers and drinks in the heart of San Francisco. Limited seats remain, secure your spot today!

Your AI vision is only as strong as the data behind it. DNAnexus turns complex omics data into governed, reusable, AI‑ready assets so you can power real‑world discovery. Join us in Boston for a diverse discussion and networking, and leave with insights on determining what in AI is geniuinely real and who to trust to deliver it.

Nobody budgets for a re-platform. In a regulated environment outgrowing your infrastructure isn't a migration, it's a revalidation. Every assay, every version, every piece of evidence, all over again. And it gets triggered not by a scientific decision, but by growth. Join us on September 30th to learn: → Why infrastructure decisions carry outsized risk as pressure on margins, turnaround time, and reimbursement intensifies → What stays constant, and what changes, from first assay to population scale → How one secure, compliant platform supports research, first clinical test, scaling production, and population-scale governance without a rebuild → How to validate that platform quickly, and at low risk, before committing Presenting: Todd Oakland, PhD (SVP & GM, Biopharma Rx/Dx), Matthew Andreatta, PhD (Presales Solutions Director), and Jamie Fornek, PhD, MPH (Sr. Director, Global Care & Content Intelligence). Save your seat 🔗 https://hubs.ly/Q04y2K3R0 #Diagnostics #Genomics #PrecisionMedicine #DNAnexus

DNAnexus partnered with precision medicine leader, Aitia Bio, to discuss how the difficulty assembling consistent, traceable evidence from diverse data sources to support timely program decisions. Watch our on-demand webinar to learn how cell, gene and RNA therapies teams can operationalize multimodal evidence to improve decision velocity, traceability and governance readiness.

See the bioinformatics software that seamlessly integrates and analyzes multi-omics data with real world data to test performance and impact on outcomes.